Moving Beyond the Drug Budget Silo Mentality in Europe

Moving beyond the drug budget silo mentality in Europe.

The drug budget silo mentality in Europe: an overview.

This supplement engages some of the leading health economists in Europe to analyze how the policies in their respective health-care systems to control and influence pharmaceutical spending are likely to influence the overall performance of their systems, with respect to both cost control and the production of population health. Six countries were selected to provide a representative mix of publ...

The drug budget silo mentality: the French case.

OBJECTIVES The objectives of this study were to give a review of the complex system of budgetary constraints to which the French health-care system has been committed since 1996 and to evaluate the consequences on drug policy and on efficient use of pharmaceuticals. METHODS Literature review, legal texts analysis, and interviews with policy makers and companies managers were performed. RESU...

The drug budget silo mentality: the Dutch case.

This article provides a broad outline of developments in the Dutch health-care policy related to the costs, budgeting, and reimbursement of pharmaceuticals. In-hospital drugs costs are part of hospital budgets, whereas for the main part of costs, nonhospital drugs, no strict budget exists. The government sets a goal for the annual cost increase of nonhospital drugs, but has only limited means t...

Drug consumption facilities in Europe and beyond

Drug consumption rooms (DCRs) are professionally supervised healthcare facilities where drug users can use drugs in safer and more hygienic conditions. Since 1986, more than 90 DCRs have been set up in Switzerland, the Netherlands, Germany, Spain, Luxembourg, Norway, Canada and Australia. Consumption rooms aim to establish contact with difficult-to-reach populations of drug users, provide an en...